Latest: Chemplast Sanmar Ltd Q1 FY27 results →All Q1 FY26 results →
CS

Chemplast Sanmar Ltd

Q1 FY26Chemicals & Petrochemicals

Chemplast Sanmar Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management said on revenue, margins and capex.

Price₹177
Market cap₹2.9K Cr
Updated23 Aug 2026
Read4 min read

The short version

Specialty business capacity built during tough quarters is expected to act as a springboard for future growth. Specialty business capacity built during the tough PVC market phase is expected to act as a springboard for future growth.

From Chemplast Sanmar Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Specialty business capacity built during tough quarters is expected to act as a springboard for future growth.
  • Custom Manufactured Chemicals Division (CMCD) shows a strong and healthy pipeline with active customer engagement, expected to accelerate from next year.
  • Agro-chemical sector is recovering, with an increase in inquiries and expected ramp-up of sales volumes in CMCD.
  • Demand for Paste PVC in India is expected to grow at 7-8% annually.
  • Suspension PVC demand outlook remains positive with 4% growth in domestic demand this quarter.
  • Government infrastructure projects are expected to drive pipe demand, supporting PVC sales growth.

2 more points from Chemplast Sanmar Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Chemplast Sanmar Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The multipurpose block Phase 3 of Custom Manufacturing is ongoing and progressing as per approved capex limits with completion expected by Q3 FY '26.
  • Civil works for the next production block, MPB 4, have also commenced with a similar timeline.
  • The R32 refrigerant gas project has received environmental clearance; however, the exact sizing and total capex are yet to be decided. Current approvals are enabling in nature.

2 more points from Chemplast Sanmar Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chemplast Sanmar Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The Custom Manufactured Chemicals Division (CMCD) dispatches are currently on track and as per schedule.
  • The multipurpose block Phase 3 expansion is progressing well, with completion expected in the next 2 to 3 months.
  • Construction for MPB 4 civil works is also nearing completion within the same timeline.
  • The pipeline of inquiries and customer engagement remains healthy and strong.
  • The company maintains very active engagement with customers, including multiple visits, audits, and inquiries over the past year.
  • Future investments and expansions in CMCD will be triggered once visibility for 60% of the current block is secured.

2 more points from Chemplast Sanmar Ltd's call on order book

Create a free account to keep reading this call

Chemplast Sanmar Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.3K Cr, net loss ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Balaji Amines (Q1 FY26)

    Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…

  • Linde India Ltd (Q1 FY26)

    Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. Key concall takeaways from Linde India Ltd's…

  • Vidhi Specialty Food Ingredients Ltd (Q1 FY26)

    87.9 Crores . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

  • Chemcon Speciality Chemicals Ltd (Q1 FY26)

    Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q1…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chemplast Sanmar Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chemplast Sanmar Ltd Q1 FY26 results?

Specialty business capacity built during tough quarters is expected to act as a springboard for future growth. Specialty business capacity built during the tough PVC market phase is expected to act as a springboard for future growth.

What is Chemplast Sanmar Ltd share price analysis?

Chemplast Sanmar Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹2,911 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemplast Sanmar Ltd planning capital expenditure?

The multipurpose block Phase 3 of Custom Manufacturing is ongoing and progressing as per approved capex limits with completion expected by Q3 FY '26. - Civil works for the next production block, MPB 4, have also commenced with a similar timeline. - The R32 refrigerant gas project has received environmental clearance; however, the exact sizing and total capex are yet to be decided.

Keep Chemplast Sanmar Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.